Parexel is one of the best opportunities in pharma right now. More
Thursday Apple Rumors: iPhone Launch Sales Predicted to Top Records
Analysts expect up to 8 million iPhones sales this weekend; Tim Cook says Apple won't make 'junk'; and lines form outside New York and London Apple Stores. More
Your Core Portfolio: More Special Situations (Shorts)
In this installment, we look at stocks worth shorting, including a couple of chronically unprofitable energy players. More
Does QE Really Matter for Gold?
The conventional wisdom is that quantitative easing boosts the price of gold, but this assertion isn't supported by gold's actual performance results. More
10 Worst “Strong Sell” Stocks This Week — NGD MTL RBY and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an "F" ("strong sell") on Portfolio Grader. Since the beginning of the year, the Nasdaq is up 10.9%, the Dow rose 13.2%, and the S&P has risen 12.1%. More
Google Bets on Healthcare — You Should, Too
Google is aiming at helping humans live longer via a new venture, Calico -- another nod at just how lucrative the healthcare space should continue to be. More
11 Restaurant and Resort Stocks to Buy Now
11 Restaurant and Resort stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
